CHARACTERIZATION AND MANAGEMENT OF CUTANEOUS REACTIONS IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH LONCASTUXIMAB TESIRINE IN THE LOTIS-2 TRIAL-MedSci.cn

CHARACTERIZATION AND MANAGEMENT OF CUTANEOUS REACTIONS IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH LONCASTUXIMAB TESIRINE IN THE LOTIS-2 TRIAL

Pruett, J; Zellner, K; Kahl, B; Ungar, D; Wang, LQ; Hamadani, M

ONCOLOGY NURSING FORUM, 2022; 49 (2): E59

科室
- - 订阅+
  - 更多科室
工具
服务